These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34046955)

  • 21. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion.
    Weinstock C; Möhle R; Dorn C; Weisel K; Höchsmann B; Schrezenmeier H; Kanz L
    Transfusion; 2015 Mar; 55(3):605-10. PubMed ID: 25251967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Ureshino H; Ando T; Kizuka H; Kusaba K; Sano H; Nishioka A; Itamura H; Shindo T; Kubota Y; Kojima K; Kimura S
    Hematol Oncol; 2018 Feb; 36(1):324-327. PubMed ID: 28971493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome with acute hepatitis E during tocilizumab treatment for rheumatoid arthritis.
    Leroy M; Coiffier G; Pronier C; Triquet L; Perdriger A; Guggenbuhl P
    Joint Bone Spine; 2015 Jul; 82(4):278-9. PubMed ID: 25791259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tocilizumab in the treatment of post-transfusion hyperhaemolysis.
    Desai N; Peters J; Davies E; Sharif J
    EJHaem; 2023 Nov; 4(4):1096-1099. PubMed ID: 38024590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S; Fenves A; Nance ST; Sykes DB; Dzik WS
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment.
    Sukharomana M; Udomittipong K; Ruangchira-Urai R; Charuvanij S
    Asian Pac J Allergy Immunol; 2022 Jun; 40(2):172-176. PubMed ID: 31837211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocilizumab for steroid refractory acute graft-versus-host disease.
    Roddy JV; Haverkos BM; McBride A; Leininger KM; Jaglowski S; Penza S; Klisovic R; Blum W; Vasu S; Hofmeister CC; Benson DM; Andritsos LA; Devine SM; Efebera YA
    Leuk Lymphoma; 2016; 57(1):81-5. PubMed ID: 26140610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegcetacoplan for paroxysmal nocturnal hemoglobinuria.
    Gerber GF; Brodsky RA
    Blood; 2022 Jun; 139(23):3361-3365. PubMed ID: 35349667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
    Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
    Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tocilizumab in Refractory Autoimmune Encephalitis: A Series of Pediatric Cases.
    Randell RL; Adams AV; Van Mater H
    Pediatr Neurol; 2018 Sep; 86():66-68. PubMed ID: 30177347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.
    Iwai A; Naniwa T; Tamechika S; Maeda S
    Mod Rheumatol; 2017 May; 27(3):529-532. PubMed ID: 25437197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    McGlennan AP; Grundy EM
    Anaesthesia; 2005 Jun; 60(6):609-12. PubMed ID: 15918834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
    Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
    Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hair-cycle changes in two patients taking tocilizumab.
    Vidon C; Bossert M; Lohse-Walliser A; Godfrin-Valnet M; Balblanc JC; Wendling D
    Joint Bone Spine; 2014 Jan; 81(1):100-1. PubMed ID: 23953226
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
    Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still's disease successfully treated with tocilizumab.
    Savage E; Wazir T; Drake M; Cuthbert R; Wright G
    Rheumatology (Oxford); 2014 Jul; 53(7):1352-3. PubMed ID: 24609056
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-N and anti-Do
    Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.